| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Naomi A Fineberg, David S Baldwin, Lynne M Drummond, Solange Wyatt, Jasmine Hanson, Srinivas Gopi, Sukhwinder Kaur, Jemma Reid, Virender Marwah, Ricky A Sachdev, Ilenia Pampaloni, Sonia Shahper, Yana Varlakova, Davis Mpavaenda, Christopher Manson, Cliodhna O'Leary, Karen Irvine, Deela Monji-Patel, Ayotunde Shodunke, Tony Dyer, Amy Dymond, Garry Barton, David Wellste. Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorder. International clinical psychopharmacology. vol 33. issue 6. 2019-05-03. PMID:30113928. |
optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorder. |
2019-05-03 |
2023-08-13 |
human |
| Naomi A Fineberg, David S Baldwin, Lynne M Drummond, Solange Wyatt, Jasmine Hanson, Srinivas Gopi, Sukhwinder Kaur, Jemma Reid, Virender Marwah, Ricky A Sachdev, Ilenia Pampaloni, Sonia Shahper, Yana Varlakova, Davis Mpavaenda, Christopher Manson, Cliodhna O'Leary, Karen Irvine, Deela Monji-Patel, Ayotunde Shodunke, Tony Dyer, Amy Dymond, Garry Barton, David Wellste. Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorder. International clinical psychopharmacology. vol 33. issue 6. 2019-05-03. PMID:30113928. |
established treatments for obsessive compulsive disorder (ocd) include cognitive behaviour therapy (cbt) and selective serotonin reuptake inhibitor (ssri) medication. |
2019-05-03 |
2023-08-13 |
human |
| Dong-Dong Zhou, Xiao-Xin Zhou, Yao Li, Kai-Fu Zhang, Zhen Lv, Xiao-Rong Chen, Li-Yang Wan, Wo Wang, Gao-Mao Wang, Da-Qi Li, Ming Ai, Li Kuan. Augmentation agents to serotonin reuptake inhibitors for treatment-resistant obsessive-compulsive disorder: A network meta-analysis. Progress in neuro-psychopharmacology & biological psychiatry. vol 90. 2019-04-22. PMID:30576763. |
augmentation agents to serotonin reuptake inhibitors for treatment-resistant obsessive-compulsive disorder: a network meta-analysis. |
2019-04-22 |
2023-08-13 |
Not clear |
| Dong-Dong Zhou, Xiao-Xin Zhou, Yao Li, Kai-Fu Zhang, Zhen Lv, Xiao-Rong Chen, Li-Yang Wan, Wo Wang, Gao-Mao Wang, Da-Qi Li, Ming Ai, Li Kuan. Augmentation agents to serotonin reuptake inhibitors for treatment-resistant obsessive-compulsive disorder: A network meta-analysis. Progress in neuro-psychopharmacology & biological psychiatry. vol 90. 2019-04-22. PMID:30576763. |
various agents for augmentation of serotonin reuptake inhibitors have been investigated for treatment-resistant obsessive-compulsive disorder (ocd). |
2019-04-22 |
2023-08-13 |
Not clear |
| Amanda J Lisoway, Gwyneth Zai, Arun K Tiwari, Clement C Zai, Karen Wigg, Vanessa Goncalves, Danning Zhang, Natalie Freeman, Daniel J Müller, James L Kennedy, Margaret A Richte. Pharmacogenetic evaluation of a DISP1 gene variant in antidepressant treatment of obsessive-compulsive disorder. Human psychopharmacology. vol 33. issue 4. 2019-04-16. PMID:29953682. |
a recent genome-wide association study (gwas) in obsessive-compulsive disorder (ocd) reported a significant marker in the dispatched homolog 1 (drosophila) gene (disp1 gene) associated with serotonin reuptake inhibitor (sri) antidepressant response (qin et al., ). |
2019-04-16 |
2023-08-13 |
drosophila_melanogaster |
| Donatella Marazziti, Maria Teresa Avella, Lucia Basile, Federico Mucci, Liliana Dell'Oss. Pharmacokinetics of serotonergic drugs: focus on OCD. Expert opinion on drug metabolism & toxicology. vol 15. issue 4. 2019-04-03. PMID:30793987. |
although the treatment of obsessive-compulsive disorder (ocd), a common, chronic, and disabling psychiatric condition, has significantly improved in the last decades, with the demonstration of the specific effectiveness of serotonin reuptake inhibitors (sris), a large proportion of patients still show high relapse rates. |
2019-04-03 |
2023-08-13 |
Not clear |
| Eszter Kenezloi, Krisztina Lakatos, Erzsebet Zsofia Horvath, Maria Sasvari-Szekely, Zsofia Nemod. A pilot study of early onset obsessive-compulsive disorder: Symptom dimensions and association analysis with polymorphisms of the serotonin transporter gene. Psychiatry research. vol 268. 2019-03-11. PMID:30121542. |
a pilot study of early onset obsessive-compulsive disorder: symptom dimensions and association analysis with polymorphisms of the serotonin transporter gene. |
2019-03-11 |
2023-08-13 |
Not clear |
| Srinivas Balachander, Prabhath Gujjadi Kodancha, Shyam Sundar Arumugham, Jaisoorya T Sekharan, Janardhanan C Narayanaswamy, Y C Janardhan Redd. Effectiveness of Venlafaxine in Selective Serotonin Reuptake Inhibitor-Resistant Obsessive-Compulsive Disorder: Experience From a Specialty Clinic in India. Journal of clinical psychopharmacology. vol 39. issue 1. 2019-03-04. PMID:30516575. |
effectiveness of venlafaxine in selective serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: experience from a specialty clinic in india. |
2019-03-04 |
2023-08-13 |
Not clear |
| Junhee Lee, Bo-Hyung Kim, Euitae Kim, Oliver D Howes, Kang Ik Kevin Cho, Youngwoo Bryan Yoon, Jun Soo Kwo. Higher serotonin transporter availability in early-onset obsessive-compulsive disorder patients undergoing escitalopram treatment: A [ Human psychopharmacology. vol 33. issue 1. 2019-02-11. PMID:29210107. |
higher serotonin transporter availability in early-onset obsessive-compulsive disorder patients undergoing escitalopram treatment: a [ early-onset obsessive-compulsive disorder (eocd) and late-onset obsessive-compulsive disorder (locd) are distinct subtypes of obsessive-compulsive disorder (ocd). |
2019-02-11 |
2023-08-13 |
Not clear |
| Donatella Marazziti, Stephen M Stah. Serotonin and Love: Supporting Evidence From a Patient Suffering From Obsessive-Compulsive Disorder. Journal of clinical psychopharmacology. vol 38. issue 1. 2019-01-07. PMID:29189409. |
serotonin and love: supporting evidence from a patient suffering from obsessive-compulsive disorder. |
2019-01-07 |
2023-08-13 |
Not clear |
| Atieh Modarresi, Mehdi Sayyah, Setareh Razooghi, Kaveh Eslami, Mohammadreza Javadi, Leila Kout. Memantine Augmentation Improves Symptoms in Serotonin Reuptake Inhibitor-Refractory Obsessive-Compulsive Disorder: A Randomized Controlled Trial. Pharmacopsychiatry. vol 51. issue 6. 2018-12-11. PMID:29100251. |
memantine augmentation improves symptoms in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder: a randomized controlled trial. |
2018-12-11 |
2023-08-13 |
Not clear |
| Jennifer I Lissemore, Debbie Sookman, Paul Gravel, Alexandre Berney, Amir Barsoum, Mirko Diksic, Thomas E Nordahl, Gilbert Pinard, Igor Sibon, Jean Cottraux, Marco Leyton, Chawki Benkelfa. Brain serotonin synthesis capacity in obsessive-compulsive disorder: effects of cognitive behavioral therapy and sertraline. Translational psychiatry. vol 8. issue 1. 2018-12-11. PMID:29666372. |
brain serotonin synthesis capacity in obsessive-compulsive disorder: effects of cognitive behavioral therapy and sertraline. |
2018-12-11 |
2023-08-13 |
Not clear |
| Jennifer I Lissemore, Debbie Sookman, Paul Gravel, Alexandre Berney, Amir Barsoum, Mirko Diksic, Thomas E Nordahl, Gilbert Pinard, Igor Sibon, Jean Cottraux, Marco Leyton, Chawki Benkelfa. Brain serotonin synthesis capacity in obsessive-compulsive disorder: effects of cognitive behavioral therapy and sertraline. Translational psychiatry. vol 8. issue 1. 2018-12-11. PMID:29666372. |
cognitive behavioral therapy (cbt) and selective serotonin reuptake inhibitors (ssris) are both effective treatments for some patients with obsessive-compulsive disorder (ocd), yet little is known about the neurochemical changes related to these treatment modalities. |
2018-12-11 |
2023-08-13 |
Not clear |
| Mohamed Abdulkadir, Douglas Londono, Derek Gordon, Thomas V Fernandez, Lawrence W Brown, Keun-Ah Cheon, Barbara J Coffey, Lonneke Elzerman, Carolin Fremer, Odette Fründt, Blanca Garcia-Delgar, Donald L Gilbert, Dorothy E Grice, Tammy Hedderly, Isobel Heyman, Hyun Ju Hong, Chaim Huyser, Laura Ibanez-Gomez, Ewgeni Jakubovski, Young Key Kim, Young Shin Kim, Yun-Joo Koh, Sodahm Kook, Samuel Kuperman, Bennett Leventhal, Andrea G Ludolph, Marcos Madruga-Garrido, Athanasios Maras, Pablo Mir, Astrid Morer, Kirsten Müller-Vahl, Alexander Münchau, Tara L Murphy, Kerstin J Plessen, Veit Roessner, Eun-Young Shin, Dong-Ho Song, Jungeun Song, Jennifer Tübing, Els van den Ban, Frank Visscher, Sina Wanderer, Martin Woods, Samuel H Zinner, Robert A King, Jay A Tischfield, Gary A Heiman, Pieter J Hoekstra, Andrea Dietric. Investigation of previously implicated genetic variants in chronic tic disorders: a transmission disequilibrium test approach. European archives of psychiatry and clinical neuroscience. vol 268. issue 3. 2018-09-11. PMID:28555406. |
17 were candidate snps implicated in ts and 2 were implicated in obsessive-compulsive disorder (ocd) or autism spectrum disorder (asd); 142 were tagging snps from eight monoamine neurotransmitter-related genes (including dopamine and serotonin); 10 were top snps from ts gwas; and 13 top snps from attention-deficit/hyperactivity disorder, ocd, or asd gwas. |
2018-09-11 |
2023-08-13 |
Not clear |
| Fatemeh Sadat Rashidi, Ehsan Ahmadipour, Sepideh Shiravand, Abolhassan Ahmadiani, Sareh Asadi, Jamal Sham. Association of the functional serotonin transporter haplotype with familial form of obsessive compulsive disorder in Iranian patients. International journal of psychiatry in clinical practice. vol 22. issue 1. 2018-08-13. PMID:28691545. |
association of the functional serotonin transporter haplotype with familial form of obsessive compulsive disorder in iranian patients. |
2018-08-13 |
2023-08-13 |
Not clear |
| Sean D Hood, Annabel Broyd, Hayley Robinson, Jessica Lee, Abdul-Rahman Hudaib, Dana A Hinc. Effects of tryptophan depletion on selective serotonin reuptake inhibitor-remitted patients with obsessive compulsive disorder. Journal of psychopharmacology (Oxford, England). vol 31. issue 12. 2018-07-11. PMID:29095069. |
effects of tryptophan depletion on selective serotonin reuptake inhibitor-remitted patients with obsessive compulsive disorder. |
2018-07-11 |
2023-08-13 |
Not clear |
| Sean D Hood, Annabel Broyd, Hayley Robinson, Jessica Lee, Abdul-Rahman Hudaib, Dana A Hinc. Effects of tryptophan depletion on selective serotonin reuptake inhibitor-remitted patients with obsessive compulsive disorder. Journal of psychopharmacology (Oxford, England). vol 31. issue 12. 2018-07-11. PMID:29095069. |
serotonergic antidepressants are first-line medication therapies for obsessive-compulsive disorder, however it is not known if synaptic serotonin availability is important for selective serotonin reuptake inhibitor efficacy. |
2018-07-11 |
2023-08-13 |
Not clear |
| Sean D Hood, Annabel Broyd, Hayley Robinson, Jessica Lee, Abdul-Rahman Hudaib, Dana A Hinc. Effects of tryptophan depletion on selective serotonin reuptake inhibitor-remitted patients with obsessive compulsive disorder. Journal of psychopharmacology (Oxford, England). vol 31. issue 12. 2018-07-11. PMID:29095069. |
the present study tested the hypothesis that temporary reduction in central serotonin transmission, through acute tryptophan depletion, would result in an increase in anxiety in selective serotonin reuptake inhibitor-remitted obsessive-compulsive disorder patients. |
2018-07-11 |
2023-08-13 |
Not clear |
| Edna Grünblatt, Zoya Marinova, Alexander Roth, Elena Gardini, Juliane Ball, Julia Geissler, Tomasz K Wojdacz, Marcel Romanos, Susanne Walitz. Combining genetic and epigenetic parameters of the serotonin transporter gene in obsessive-compulsive disorder. Journal of psychiatric research. vol 96. 2018-07-06. PMID:29102815. |
combining genetic and epigenetic parameters of the serotonin transporter gene in obsessive-compulsive disorder. |
2018-07-06 |
2023-08-13 |
Not clear |
| Qiang Lu, Suguru Komenoi, Takako Usuki, Daisuke Takahashi, Fumio Sakan. Abnormalities of the serotonergic system in diacylglycerol kinase δ-deficient mouse brain. Biochemical and biophysical research communications. vol 497. issue 4. 2018-04-10. PMID:29486157. |
we previously reported that brain-specific diacylglycerol kinase (dgk) δ-knockout (ko) mice showed obsessive-compulsive disorder (ocd)-like behaviors, which were alleviated by a serotonin (5-ht) transporter (sert) inhibitor. |
2018-04-10 |
2023-08-13 |
mouse |